시장보고서

상품코드

1562326

유럽의 만성 통증용 척수 자극기 시장 예측(-2030년) : 지역별 분석 - 제품 유형, 용도 및 최종 사용자별

Europe Spinal Cord Stimulation Device for Chronic Pain Market Forecast to 2030 - Regional Analysis - by Product Type, Application, and End User

발행일: 2024년 07월 | 리서치사:

The Insight Partners | 페이지 정보: 영문 157 Pages | 배송안내 : 즉시배송

샘플 요청 목록에 추가

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

만성 통증용 척수 자극기 시장은 2022년 7억 9,987만 달러로 평가되었고, 2030년에는 14억 1,201만 달러에 달할 것으로 예상되며, 2022-2030년간 7.4%의 연평균 복합 성장률(CAGR)을 나타낼 전망입니다.

척수 손상에 대한 효과적인 치료를 제공하는 재활 및 전문센터가 만성 통증에 대한 척수 자극기 시장을 견인할 것으로 예상됩니다.

NIH 보고서에 따르면 척수 손상 전문 치료 센터는 환자 치료와 신경학적 회복을 개선하기 위해 영국에서 처음으로 설립되었으며, SCI 삼차 의료 센터는 급성 SCI 환자의 임상 결과와 신경학적 회복을 개선하기 위해 개발되었습니다. 또한 독일 하이델베르크 대학병원의 척수 손상 센터는 척수 손상 치료 및 연구에 전념하는 유일한 학술 센터입니다. 하이델베르크 대학병원은 145명의 직원이 연간 약 1,500명의 급성 또는 만성 척수손상 환자를 치료하고 있으며, 그 중 1,000명이 외래에서 치료를 받고 있습니다.

척수 자극기는 재활센터에서 많이 사용되고 있습니다. 이러한 장비에 기반한 치료법은 환자를 신체적, 심리적으로 지원하여 단기간에 신경학적 회복과 전신 건강을 극대화할 수 있도록 돕습니다. 베를린에 위치한 워크 어게인 센터(Walk Again Center)는 신경 질환을 치료하는 재활센터의 한 예입니다. 이 재활센터는 척수 손상을 치료하는 데 의학과 기술을 모두 적용합니다. 의사는 구조적, 신경학적 신경가소성 등 혁신적인 치료법을 사용하여 뇌 손상으로 고통받는 환자들에게 치료를 제공합니다. 따라서 첨단 재활센터와 전문센터는 유럽의 만성 통증용 척수 자극기 시장에 성장 기회를 제공합니다.

유럽의 만성통증용 척수 자극기 시장 개요

유럽의 만성 통증용 척수 자극기 시장은 지역별로 독일, 프랑스, 이탈리아, 스페인, 영국, 스위스, 네덜란드, 스웨덴, 기타 유럽으로 구분됩니다. 의료비 청구 증가 및 관련 비용 증가, 행정 거래 증가, 공급망 추적에서 만성 통증용 척수 자극기 플랫폼은 시장 성장을 가속하는 주요 요인 중 하나입니다. 예를 들어, 이탈리아의 경우, 병원에서의 척수 치료는 이탈리아 국민건강보험(NHS)을 통해 보험이 적용됩니다. 따라서 이탈리아 국민들은 척수 손상에 대한 효과적인 치료법이 있다는 인식이 높습니다. 따라서 척수 손상에 대한 적절한 의료 보험 규정이 있다는 것은 이탈리아 병원과 전문센터에서 척수 자극기에 대한 수요가 높다는 것을 의미합니다.

유럽 만성통증용 척수자극기 시장 매출 및 2030년까지의 예측(금액)

만성통증용 척수자극기 유럽 시장 세분화

만성통증용 척수 자극기 시장은 제품 유형, 용도, 최종 사용자, 국가별로 세분화되어 있습니다.

제품 유형에 따라 만성 통증용 척수 자극기 시장은 충전식 및 비충전식으로 구분되며, 2022년에는 충전식 부문이 더 큰 점유율을 차지할 것으로 예상됩니다.

용도별로 만성 통증용 척수 자극기 시장은 요추부 고장 증후군, 복합 국소 통증 증후군, 퇴행성 디스크 질환, 기타로 분류됩니다. 복합부위통증증후군 부문이 2022년 가장 큰 점유율을 차지할 것으로 예상됩니다.

최종 사용자별로 만성 통증용 척수 자극기 시장은 병원, 외래수술센터(ASC)(ASCS), 기타로 구분됩니다. 병원 부문이 2022년 가장 큰 점유율을 차지했습니다.

국가별로 만성 통증용 척수 자극기 시장은 독일, 프랑스, 영국, 스페인, 이탈리아, 스위스, 스웨덴, 폴란드, 벨기에, 슬로바키아, 체코, 그리스, 아일랜드, 네덜란드, 기타 유럽으로 분류됩니다. 독일이 2022년 만성 통증용 척수 자극기 시장을 독점했습니다.

Boston Scientific Corp, Abbott Laboratories, Medtronic Plc, Biotronik SE &Co KG, Nevro Corp, Cirtec Medical Corp, Synapse Biomedical Inc는 유럽 만성통증 유럽 만성통증 척추자극기 시장에서 사업을 전개하고 있는 주요 기업입니다.

According to a report by the NIH, specialized centers of care for SCI were first established in England with an objective to improve the care and neurological recovery of patients. SCI tertiary care centers are developed to improve clinical outcomes and neurological recovery among patients suffering from acute SCIs. Additionally, the Spinal Cord Injury Center at Heidelberg University Hospital in Germany is the only academic center dedicated to the treatment and research of SCIs. The staff at Heidelberg University Hospital, including ~145 staff members, provides treatment to ~1,500 patients suffering from acute or chronic spinal cord injuries annually, among which 1,000 receive outpatient care.

Spinal cord stimulation devices are highly adopted in rehabilitation centers. A treatment method based on these devices supports patients physically and psychologically to maximize their neurological recovery and general health in a short time. The Walk Again Center based in Berlin is one such example of a rehabilitation center to treat neurological conditions. This rehab center employs both medicine and technology to treat SCIs. It uses innovative medical procedures, including structural and neural neuroplasticity, where doctors provide therapy to patients suffering from brain damage. Therefore, advanced rehab centers and specialized centers provide growth opportunities to the Europe spinal cord stimulation devices for chronic pain market.

Europe Spinal Cord Stimulation Device for Chronic Pain Market Overview

Europe spinal cord stimulation device for chronic pain market by region, is segmented as Germany, France, Italy, Spain, United Kingdom, Switzerland, Netherlands, Sweden, and Rest of Europe. The rising healthcare claims and associated costs, increasing administrative transactions, and spinal cord stimulation device for chronic pain platform in supply chain tracking are among the prominent factors propelling the market growth. for instance, in Italy, spinal cord treatments in hospitals are fully covered under insurance through the Italian National Health System (NHS). Therefore, there is high awareness of effective treatments available for SCIs among the Italian population. Therefore, the availability of proper health coverage provisions for SCI signifies a high demand for spinal cord stimulation devices among hospitals and specialty centers in Italy.

Europe Spinal Cord Stimulation Device for Chronic Pain Market Revenue and forecast to 2030 (US$ Million)

Europe Spinal Cord Stimulation Device for Chronic Pain Market Segmentation

The spinal cord stimulation device for chronic pain market is segmented based on product type, application, end user, and country.

Based on product type, the spinal cord stimulation device for chronic pain market is bifurcated into rechargeable and non-rechargeable. The rechargeable segment held a larger share in 2022.

In terms of application, the spinal cord stimulation device for chronic pain market is segmented into failed back syndrome, complex regional pain syndrome, degenerative disk disease, and others. The complex regional pain syndrome segment held the largest share in 2022.

By end user, the spinal cord stimulation device for chronic pain market is segmented into hospitals, ambulatory surgery centers (ASCS), and others. The hospitals segment held the largest share in 2022.

Based on country, the spinal cord stimulation device for chronic pain market is categorized into Germany, France, the UK, Spain, Italy, Switzerland, Sweden, Poland, Belgium, Slovakia, Czech Republic, Greece, Ireland, the Netherland, and the Rest of Europe. Germany dominated the spinal cord stimulation device for chronic pain market in 2022.

Boston Scientific Corp, Abbott Laboratories, Medtronic Plc, Biotronik SE & Co KG, Nevro Corp, Cirtec Medical Corp, and Synapse Biomedical Inc are some of the leading companies operating in the Europe spinal cord stimulation device for chronic pain market.

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
- 1.2.1 Europe Spinal Cord Stimulation Device for Chronic Pain Market - by Product Type
- 1.2.2 Europe Spinal Cord Stimulation Device for Chronic Pain Market - by Application
- 1.2.3 Europe Spinal Cord Stimulation Device for Chronic Pain Market - by End User
- 1.2.4 Europe Spinal Cord Stimulation Device for Chronic Pain Market - by Country

2. Europe Spinal Cord Stimulation Device for Chronic Pain Market - Key Takeaways

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Europe Spinal Cord Stimulation Device for Chronic Pain Market - Market Landscape

4.1 Company Share Analysis
4.2 Pricing Analysis

5. Europe Spinal Cord Stimulation Device for Chronic Pain Market

5.1 Market Drivers
- 5.1.1 Rising Number of Spinal Cord Injuries
- 5.1.2 Availability of Innovative Treatments in European Union
5.2 Market Restraints
- 5.2.1 Product Recalls
5.3 Market Opportunities
- 5.3.1 Rehabilitation and Specialized Centers Providing Effective Treatment for Spinal Cord Injuries
5.4 Future Trends
- 5.4.1 Regenerative and Innovative Implant-Based Therapeutic Approaches
5.5 Impact analysis

6. Spinal Cord Stimulation Device for Chronic Pain Market - Europe Analysis

6.1 Europe Spinal Cord Stimulation Device for Chronic Pain Market Revenue Forecast and Analysis

7. Europe Spinal Cord Stimulation Device for Chronic Pain Market - Revenue and Forecast to 2030 - by Product Type

7.1 Overview
7.2 Europe Spinal Cord Stimulation Device for Chronic Pain Market Revenue Share, by Product Type, 2022 & 2030 (%)
7.3 Rechargeable
- 7.3.1 Overview
- 7.3.2 Rechargeable: Europe Spinal Cord Stimulation Device for Chronic Pain Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Non-Rechargeable
- 7.4.1 Overview
- 7.4.2 Non-Rechargeable: Europe Spinal Cord Stimulation Device for Chronic Pain Market - Revenue and Forecast to 2030 (US$ Million)

8. Europe Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecasts to 2030- by Application

8.1 Overview
- 8.1.1 Europe Spinal Cord Stimulation Device for Chronic Pain Market Revenue Share, by Application (2022 and 2030)
8.2 Failed Back Syndrome
- 8.2.1 Overview
- 8.2.2 Failed Back Syndrome: Europe Spinal Cord Stimulation Device for Chronic Pain Market- Revenue and Forecast to 2030 (US$ Million)
8.3 Complex Regional Pain Syndrome
- 8.3.1 Overview
- 8.3.2 Complex Regional Pain Syndrome: Europe Spinal Cord Stimulation Device for Chronic Pain Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Degenerative Disk Disease
- 8.4.1 Overview
- 8.4.2 Degenerative Disk Disease: Europe Spinal Cord Stimulation Device for Chronic Pain Market - Revenue and Forecast to 2030 (US$ Million)
8.5 Others
- 8.5.1 Overview
- 8.5.2 Others: Europe Spinal Cord Stimulation Device for Chronic Pain Market - Revenue and Forecast to 2030 (US$ Million)

9. Europe Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecasts to 2030- by End User

9.1 Overview
9.2 Europe Spinal Cord Stimulation Device for Chronic Pain Market Revenue Share, by End User (2022 and 2030)
9.3 Hospitals
- 9.3.1 Overview
- 9.3.2 Hospitals: Europe Spinal Cord Stimulation Device for Chronic Pain Market- Revenue and Forecast to 2030 (US$ Million)
9.4 Ambulatory Surgery Centers (ASCs)
- 9.4.1 Overview
- 9.4.2 Ambulatory Surgery Centers (ASCs): Europe Spinal Cord Stimulation Device for Chronic Pain Market - Revenue and Forecast to 2030 (US$ Million)
9.5 Others
- 9.5.1 Overview
- 9.5.2 Others: Europe Spinal Cord Stimulation Device for Chronic Pain Market - Revenue and Forecast to 2030 (US$ Million)

10. Europe Spinal Cord Stimulation Device for Chronic Pain Market - Revenue and Forecast to 2030 -Country Analysis

10.1 Europe Spinal Cord Stimulation Device for Chronic Pain Market, Revenue and Forecast to 2030
- 10.1.1 Overview
  - 10.1.1.1 Europe: Spinal Cord Stimulation Device for Chronic Pain Market, by Countries
  - 10.1.1.2 Germany
    - 10.1.1.2.1 Overview
    - 10.1.1.2.2 Germany: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)
    - 10.1.1.2.3 Germany: Spinal Cord Stimulation Device for Chronic Pain Market, by Product Type
    - 10.1.1.2.4 Germany: Spinal Cord Stimulation Device for Chronic Pain Market, by Application
    - 10.1.1.2.5 Germany: Spinal Cord Stimulation Device for Chronic Pain Market, by End User
  - 10.1.1.3 France
    - 10.1.1.3.1 Overview
    - 10.1.1.3.2 France: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)
    - 10.1.1.3.3 France: Spinal Cord Stimulation Device for Chronic Pain Market, by Product Type
    - 10.1.1.3.4 France: Spinal Cord Stimulation Device for Chronic Pain Market, by Application
    - 10.1.1.3.5 France: Spinal Cord Stimulation Device for Chronic Pain Market, by End User
  - 10.1.1.4 Italy
    - 10.1.1.4.1 Overview
    - 10.1.1.4.2 Italy: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)
    - 10.1.1.4.3 Italy: Spinal Cord Stimulation Device for Chronic Pain Market, by Product Type
    - 10.1.1.4.4 Italy: Spinal Cord Stimulation Device for Chronic Pain Market, by Application
    - 10.1.1.4.5 Italy: Spinal Cord Stimulation Device for Chronic Pain Market, by End User
  - 10.1.1.5 Spain
    - 10.1.1.5.1 Overview
    - 10.1.1.5.2 Spain: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)
    - 10.1.1.5.3 Spain: Spinal Cord Stimulation Device for Chronic Pain Market, by Product Type
    - 10.1.1.5.4 Spain: Spinal Cord Stimulation Device for Chronic Pain Market, by Application
    - 10.1.1.5.5 Spain: Spinal Cord Stimulation Device for Chronic Pain Market, by End User
  - 10.1.1.6 United Kingdom
    - 10.1.1.6.1 Overview
    - 10.1.1.6.2 United Kingdom: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)
    - 10.1.1.6.3 United Kingdom: Spinal Cord Stimulation Device for Chronic Pain Market, by Product Type
    - 10.1.1.6.4 United Kingdom: Spinal Cord Stimulation Device for Chronic Pain Market, by Application
    - 10.1.1.6.5 United Kingdom: Spinal Cord Stimulation Device for Chronic Pain Market, by End User
  - 10.1.1.7 Switzerland
    - 10.1.1.7.1 Overview
    - 10.1.1.7.2 Switzerland: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)
    - 10.1.1.7.3 Switzerland: Spinal Cord Stimulation Device for Chronic Pain Market, by Product Type
    - 10.1.1.7.4 Switzerland: Spinal Cord Stimulation Device for Chronic Pain Market, by Application
    - 10.1.1.7.5 Switzerland: Spinal Cord Stimulation Device for Chronic Pain Market, by End User
  - 10.1.1.8 Netherlands
    - 10.1.1.8.1 Overview
    - 10.1.1.8.2 Netherlands: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)
    - 10.1.1.8.3 Netherlands: Spinal Cord Stimulation Device for Chronic Pain Market, by Product Type
    - 10.1.1.8.4 Netherlands: Spinal Cord Stimulation Device for Chronic Pain Market, by Application
    - 10.1.1.8.5 Netherlands: Spinal Cord Stimulation Device for Chronic Pain Market, by End User
  - 10.1.1.9 Sweden
    - 10.1.1.9.1 Overview
    - 10.1.1.9.2 Sweden: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)
    - 10.1.1.9.3 Sweden: Spinal Cord Stimulation Device for Chronic Pain Market, by Product Type
    - 10.1.1.9.4 Sweden: Spinal Cord Stimulation Device for Chronic Pain Market, by Application
    - 10.1.1.9.5 Sweden: Spinal Cord Stimulation Device for Chronic Pain Market, by End User
  - 10.1.1.10 Belgium
    - 10.1.1.10.1 Overview
    - 10.1.1.10.2 Belgium: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)
    - 10.1.1.10.3 Belgium: Spinal Cord Stimulation Device for Chronic Pain Market, by Product Type
    - 10.1.1.10.4 Belgium: Spinal Cord Stimulation Device for Chronic Pain Market, by Application
    - 10.1.1.10.5 Belgium: Spinal Cord Stimulation Device for Chronic Pain Market, by End User
  - 10.1.1.11 Poland
    - 10.1.1.11.1 Overview
    - 10.1.1.11.2 Poland: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)
    - 10.1.1.11.3 Poland: Spinal Cord Stimulation Device for Chronic Pain Market, by Product Type
    - 10.1.1.11.4 Poland: Spinal Cord Stimulation Device for Chronic Pain Market, by Application
    - 10.1.1.11.5 Poland: Spinal Cord Stimulation Device for Chronic Pain Market, by End User
  - 10.1.1.12 Slovakia
    - 10.1.1.12.1 Overview
    - 10.1.1.12.2 Slovakia: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)
    - 10.1.1.12.3 Slovakia: Spinal Cord Stimulation Device for Chronic Pain Market, by Product Type
    - 10.1.1.12.4 Slovakia: Spinal Cord Stimulation Device for Chronic Pain Market, by Application
    - 10.1.1.12.5 Slovakia: Spinal Cord Stimulation Device for Chronic Pain Market, by End User
  - 10.1.1.13 Czech Republic
    - 10.1.1.13.1 Overview
    - 10.1.1.13.2 Czech Republic: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)
    - 10.1.1.13.3 Czech Republic: Spinal Cord Stimulation Device for Chronic Pain Market, by Product Type
    - 10.1.1.13.4 Czech Republic: Spinal Cord Stimulation Device for Chronic Pain Market, by Application
    - 10.1.1.13.5 Czech Republic: Spinal Cord Stimulation Device for Chronic Pain Market, by End User
  - 10.1.1.14 Greece
    - 10.1.1.14.1 Overview
    - 10.1.1.14.2 Greece: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)
    - 10.1.1.14.3 Greece: Spinal Cord Stimulation Device for Chronic Pain Market, by Product Type
    - 10.1.1.14.4 Greece: Spinal Cord Stimulation Device for Chronic Pain Market, by Application
    - 10.1.1.14.5 Greece: Spinal Cord Stimulation Device for Chronic Pain Market, by End User
  - 10.1.1.15 Ireland
    - 10.1.1.15.1 Overview
    - 10.1.1.15.2 Ireland: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)
    - 10.1.1.15.3 Ireland: Spinal Cord Stimulation Device for Chronic Pain Market, by Product Type
    - 10.1.1.15.4 Ireland: Spinal Cord Stimulation Device for Chronic Pain Market, by Application
    - 10.1.1.15.5 Ireland: Spinal Cord Stimulation Device for Chronic Pain Market, by End User
  - 10.1.1.16 Rest of Europe
    - 10.1.1.16.1 Overview
    - 10.1.1.16.2 Rest of Europe: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)
    - 10.1.1.16.3 Rest of Europe: Spinal Cord Stimulation Device for Chronic Pain Market, by Product Type
    - 10.1.1.16.4 Rest of Europe: Spinal Cord Stimulation Device for Chronic Pain Market, by Application
    - 10.1.1.16.5 Rest of Europe: Spinal Cord Stimulation Device for Chronic Pain Market, by End User

11. Industry Landscape

11.1 Overview
11.2 Growth Strategies Done by the Companies in the Market (%)
11.3 Organic Developments
- 11.3.1 Overview
11.4 Inorganic Developments
- 11.4.1 Overview

12. Company Profiles

12.1 Boston Scientific Corp
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 Abbott Laboratories
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 Medtronic Plc
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Biotronik SE & Co KG
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 Nevro Corp
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 Cirtec Medical Corp
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 Synapse Biomedical Inc
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments

13. Appendix

13.1 About The Insight Partners
13.2 Glossary of Terms

유럽의 만성 통증용 척수 자극기 시장 예측(-2030년) : 지역별 분석 - 제품 유형, 용도 및 최종 사용자별

Europe Spinal Cord Stimulation Device for Chronic Pain Market Forecast to 2030 - Regional Analysis - by Product Type, Application, and End User

목차

제1장 서론

제2장 유럽의 만성 통증용 척수자극기 시장 : 요점

제3장 조사 방법

제4장 유럽의 만성 통증용 척수자극기 시장 : 시장 구도

제5장 만성 통증용 척수자극기 유럽 시장

제6장 만성 통증용 척수자극기 시장 : 유럽 분석

제7장 유럽의 만성 통증용 척수자극기 시장 매출과 2030년까지 예측 : 제품 유형별

제8장 유럽의 만성 통증용 척수자극기 시장 매출과 2030년까지 예측 : 용도별

제9장 유럽의 만성 통증용 척수자극기 시장 매출과 2030년까지 예측 : 최종사용자별

제10장 유럽의 만성 통증용 척수자극기 시장 매출과 2030년까지 예측 : 국가별 분석

제11장 업계 상황

제12장 기업 개요

제13장 부록

Table Of Contents